NOVARTIS N - 1H - Technical analysis published on 04/29/2023 (GMT)
- 243
- 0
Click here for a new analysis!
- Timeframe : 1H
- - Analysis generated on
- Status : TARGET REACHED
Analysis too old. There are no more charts available.
Summary of the analysis
Additional analysis
Quotes
NOVARTIS N rating 91.1300 CHF. The price is lower by -0.24% since the last closing with the lowest point at 90.8200 CHF and the highest point at 92.0300 CHF. The deviation from the price is +0.34% for the low point and -0.98% for the high point.A bullish opening was detected by the Central Gaps scanner. Buyers are trying to impose a bullish momentum in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
New HIGH record (5 years)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 year)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
Technical analysis of this 1H chart of NOVARTIS N indicates that the overall trend is bullish. The signals given by moving averages are 67.86% bullish. This bullish trend could slow down given the slightly bearish signals currently being given by short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
In fact, of the 18 technical indicators analysed by Central Analyzer, 4 are bullish, 8 are neutral and 6 are bearish. Other results related to technical indicators were also found by the Central Indicators scanner:
Pivot points : price is over resistance 2
Type : Neutral
Timeframe : Weekly
Parabolic SAR indicator bullish reversal
Type : Bullish
Timeframe : 1 hour
The analysis of the price chart with Central Patterns scanners does not return any result.
For a small setback in the very short term, the Central Candlesticks scanner currently notes the presence of this bearish pattern in Japanese candlesticks:
Black gravestone / inverted hammer
Type : Bearish
Timeframe : 1 hour
S3 | S2 | S1 | Price | R1 | R2 | |
---|---|---|---|---|---|---|
ProTrendLines | 88.5500 | 89.8471 | 91.0800 | 91.1300 | 92.3728 | 93.9500 |
Change (%) | -2.83% | -1.41% | -0.05% | - | +1.36% | +3.09% |
Change | -2.5800 | -1.2829 | -0.0500 | - | +1.2428 | +2.8200 |
Level | Major | Intermediate | Intermediate | - | Major | Major |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 89.4133 | 90.1167 | 90.6233 | 91.3267 | 91.8333 | 92.5367 | 93.0433 |
Camarilla | 90.7973 | 90.9082 | 91.0191 | 91.1300 | 91.2409 | 91.3518 | 91.4628 |
Woodie | 89.3150 | 90.0675 | 90.5250 | 91.2775 | 91.7350 | 92.4875 | 92.9450 |
Fibonacci | 90.1167 | 90.5789 | 90.8645 | 91.3267 | 91.7889 | 92.0745 | 92.5367 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 84.3533 | 86.8367 | 88.9833 | 91.4667 | 93.6133 | 96.0967 | 98.2433 |
Camarilla | 89.8568 | 90.2812 | 90.7056 | 91.1300 | 91.5544 | 91.9788 | 92.4033 |
Woodie | 84.1850 | 86.7525 | 88.8150 | 91.3825 | 93.4450 | 96.0125 | 98.0750 |
Fibonacci | 86.8367 | 88.6053 | 89.6980 | 91.4667 | 93.2353 | 94.3280 | 96.0967 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 66.3667 | 70.0533 | 76.9067 | 80.5933 | 87.4467 | 91.1333 | 97.9867 |
Camarilla | 80.8615 | 81.8277 | 82.7938 | 83.7600 | 84.7262 | 85.6923 | 86.6585 |
Woodie | 67.9500 | 70.8450 | 78.4900 | 81.3850 | 89.0300 | 91.9250 | 99.5700 |
Fibonacci | 70.0533 | 74.0796 | 76.5671 | 80.5933 | 84.6196 | 87.1071 | 91.1333 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
RSI (14): | 45.03 | |
MACD (12,26,9): | -0.1074 | |
Directional Movement: | 1.4120 | |
AROON (14): | -92.8571 | |
DEMA (21): | 91.3748 | |
Parabolic SAR (0,02-0,02-0,2): | 90.8200 | |
Elder Ray (13): | -0.0685 | |
Super Trend (3,10): | 92.1469 | |
Zig ZAG (10): | 91.1300 | |
VORTEX (21): | 0.8038 | |
Stochastique (14,3,5): | 21.13 | |
TEMA (21): | 90.9288 | |
Williams %R (14): | -74.38 | |
Chande Momentum Oscillator (20): | -0.5000 | |
Repulse (5,40,3): | -0.1967 | |
ROCnROLL: | -1 | |
TRIX (15,9): | -0.0005 | |
Courbe Coppock: | 1.62 |
MA7: | 90.5471 | |
MA20: | 87.7835 | |
MA50: | 82.2338 | |
MA100: | 82.9158 | |
MAexp7: | 91.1779 | |
MAexp20: | 91.4223 | |
MAexp50: | 90.9795 | |
MAexp100: | 89.6461 | |
Price / MA7: | +0.64% | |
Price / MA20: | +3.81% | |
Price / MA50: | +10.82% | |
Price / MA100: | +9.91% | |
Price / MAexp7: | -0.05% | |
Price / MAexp20: | -0.32% | |
Price / MAexp50: | +0.17% | |
Price / MAexp100: | +1.66% |
News
Don't forget to follow the news on NOVARTIS N. At the time of publication of this analysis, the latest news was as follows:
- Bicycle Therapeutics Announces a Strategic Collaboration with Novartis to Discover, Develop and Commercialize Bicycle® Radio-Conjugates
- Novartis shares Zolgensma long-term data demonstrating sustained durability up to 7.5 years post-dosing; 100% achievement of all assessed milestones in children treated prior to SMA symptom onset
- Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma, the most common pediatric brain cancer
- Thinking about trading options or stock in AstraZeneca, Jacobs Solutions, J M Smucker, Tesla, or Novartis?
- INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Novartis AG with Losses of $100,000 to Contact the Firm
Add a comment
Comments
0 comments on the analysis NOVARTIS N - 1H